ANRO
Alto Neuroscience, Inc.
24.00$
+2.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.8% | 98.6% | 99.2% | 99.0% | 95.8% | 95.4% | 95.1% | 94.9% | 94.9% | 96.2% | 97.4% | 97.3% | |
| 96.3% | 95.3% | 98.1% | 97.9% | 94.8% | 94.8% | 93.5% | 93.5% | 93.7% | 95.6% | 95.5% | 95.9% | |
| 96.3% | 95.3% | 98.1% | 97.9% | 94.8% | 94.8% | 93.5% | 93.5% | 93.7% | 95.6% | 95.5% | 95.9% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 1.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 214.8% | 182.7% | 8.0% | 8.9% | 13.9% | 14.7% | 19.1% | 21.8% | 24.1% | 18.2% | 11.9% | 13.7% | |
| 11.2% | 6.5% | 3.8% | 5.0% | 7.3% | 5.6% | 4.2% | 5.1% | 6.2% | 6.1% | 4.7% | 6.6% | |
| 0.4% | 0.1% | 0.6% | 1.2% | 2.2% | 0.5% | 0.5% | 0.6% | 0.8% | 0.9% | 0.8% | 1.5% | |
| 3.3% | 1.2% | 1.1% | 0.9% | 1.2% | 0.9% | 0.8% | 1.1% | 1.4% | 1.0% | 1.2% | 1.6% | |
| 18.3% | 11.4% | 4.2% | 3.9% | 4.1% | 6.5% | 12.3% | 14.0% | 15.3% | 10.0% | 5.9% | 5.9% | |
| -114.8% | -82.7% | 92.0% | 91.1% | 86.1% | 85.3% | 80.9% | 78.2% | 75.9% | 81.8% | 88.1% | 86.3% | |
| -123.5% | -88.8% | -43.1% | -53.9% | -64.3% | -78.0% | -89.3% | -108.5% | -126.2% | -109.2% | -82.5% | -100.6% | |
| 50.5% | 31.0% | 12.8% | 13.7% | 14.1% | 15.2% | 15.7% | 17.1% | 18.4% | 17.3% | 11.9% | 16.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.